“…Several other studies among professionals in the Brazilian Amazon ubiquitously argue antivenom as an essential medicine in CHCs [ 2 , 4 , 5 , 8 , 11 , 13 – 15 , 17 , 19 , 47 , 48 ]. In addition, research on snakebite envenoming care across India [ 49 , 50 ], French Guiana [ 51 ], Burkina Faso [ 52 ], and Myanmar [ 53 ] highlights the need for antivenom availability and accompanying equipment in their primary health care centers. A multi-country study regarding access to antivenom in Malaysia, Thailand, Indonesia, Philippines, Vietnam, Lao PDR, and Myanmar also explicitly argues “strengthening the supply chain of antivenoms to ensure that antivenoms are readily accessible at the point of service,” primary health units [ 54 ].…”